MAPT and Alzheimer disease: Drug discovery for preventing amyloid-β and tau aggregation or hyperphosphorylation in Alzheimer's disease (AD) has also been done in previous years (Brandt et al., 2009; Fatouros et al., 2012; Alexander et al., 2014; Manalo et al., 2017).